Dr. Marchand does not publish alone. The research that carries his name is produced by a standing team of physician investigators, methodologists and research associates working with him at the Marchand Institute for Minimally Invasive Surgery in Mesa, Arizona.
Every name below appears as a credited author on the published work. There is no ghost authorship and there are no honorary authors. Journalists and editors are welcome to contact any listed investigator through maria@marchandobgyn.com.
Leadership
Greg J. Marchand, MD, FACS, FACOG, FICS
Director and Principal Investigator
Dual board-certified in Obstetrics and Gynecology and holder of the ABOG Focused Practice Designation in Minimally Invasive Gynecologic Surgery. Program Director of the SLS-accredited Fellowship in Minimally Invasive and Robotic Gynecologic Surgery. Senior or first author on the majority of the team’s peer-reviewed output, Principal Investigator on eight industry-sponsored FDA clinical trials, and inventor on three issued United States patents. Editorial board member for BMC Women’s Health, BMC Pregnancy and Childbirth, and the American Journal of Clinical Case Reports. NIH Early Stage Investigator.
ORCID 0000-0003-4724-9148 · Full biography and CV
Ali Azadi, MD
Collaborating Senior Investigator — Urogynecology and Pelvic Reconstructive Surgery
Senior co-author on Dr. Marchand’s urogynecology and vaginal surgery research, including meta-analyses of laparoscopic versus vaginal uterosacral ligament suspension, uterine-preserving prolapse repair, and vaginal natural orifice transluminal endoscopic surgery. Co-editor of the Textbook of Minimally Invasive Gynecologic Surgery (CRC Press, 2026), in which he co-authored the chapter on principles of vaginal surgery and vNOTES with Dr. Marchand and Dr. Jan Baekelandt.
Physician Investigators
Katelyn M. Sainz, MD
Investigator — Obstetrics and Maternal-Fetal Outcomes
First author of the team’s systematic review of neonatal ischemic encephalopathy in operative vaginal delivery versus cesarean at complete dilation (American Journal of Perinatology, 2026) and of the updated meta-analysis of maternal and neonatal outcomes of cannabis use in pregnancy (Maternal Health, Neonatology and Perinatology, 2025). Long-standing contributor across Dr. Marchand’s obstetric research line.
Fatma Ibrahim, MD
Investigator — Evidence Synthesis
Contributing author on recent meta-analyses including single- versus double-layer uterine closure and cesarean scar outcomes, and the analysis of lower-carbohydrate and lower-glycemic-index diets in pregnancy.
Ahmed Taher Masoud, MD
Research Methodologist
Statistical and methodological lead on a large share of the team’s meta-analytic output, including the JAMA Network Open analysis of birth outcomes after in-utero marijuana exposure and the AJOG Global Reports analysis of COVID-19 in pregnancy. Specialist in random-effects pooling, heterogeneity assessment and network meta-analysis.
Ahmed T. Abdelsattar, MD
Investigator — Evidence Synthesis
Contributing author on the team’s work in laparoendoscopic single-site ovarian cystectomy, RSVpreF vaccination in pregnancy, and radical hysterectomy for early stage cervical cancer.
Research Associates
Dr. Marchand’s research associates carry out protocol registration, systematic literature searching, dual independent screening, data extraction, risk-of-bias appraisal and manuscript preparation. All are credited authors on the studies they work on.
- Daniela Gonzalez Herrera, BS — Senior Research Associate. Co-author on the current cesarean closure, salpingectomy, pediatric adnexal mass, cervical cytology and ectopic pregnancy lines.
- Mckenna Robinson, BS — Senior Research Associate. Co-author across the current uterine closure, robotic single-site hysterectomy, ovarian cystectomy and neonatal outcomes work.
- Sarah Mera, BS — Research Associate. Cesarean scar outcomes, opportunistic salpingectomy, pediatric adnexal masses, cervical cytology.
- Brooklynn O’Connell, BS — Research Associate. Uterine closure, adnexal mass surgery, miniature versus single-port laparoscopy, Bulkamid for stress urinary incontinence.
- Emily Kline, BS — Research Associate. Ovarian cystectomy, pediatric adnexal masses, cervical cytology, ectopic pregnancy, salpingectomy and ovarian cancer incidence.
- Michelle Koshaba, BS — Research Associate. Salpingectomy and ovarian cancer incidence, cervical cytology, pediatric adnexal masses, dietary intervention in pregnancy.
- Nidhi Pulicherla, BA — Research Associate. Cervical cytology, ectopic pregnancy, neonatal outcomes, pediatric adnexal masses.
- A. Palma — Research Associate. Uterine closure, adnexal mass surgery, miniature versus single-port laparoscopy, Bulkamid systematic review.
- D. Anderson — Research Associate. Adnexal mass surgery, miniature versus single-port laparoscopy, Bulkamid systematic review.
- Giovanna Jephson — Research Associate. Salpingectomy and ovarian cancer incidence, cervical cytology, ectopic pregnancy.
Program Administration
Maria A. Sainz
Director of Communications and Media Relations; Fellowship Program Coordinator
Primary point of contact for media inquiries, fellowship applications and collaboration proposals. maria@marchandobgyn.com · (480) 999-0905
Recent Contributing Authors
The following colleagues have been credited authors on Dr. Marchand’s publications and presentations over the past several years, and many continue to contribute: Hollie Ulibarri, Alexa Arroyo, Brooke Hamilton, Katelynne Ruffley, Marisa Dominick, Marissa Blanco, Emily Emerson, Alexandra Sabin, Sarah Kayser, Malini Govindan, Kelly Ware, Alexa King, Sarah Ruther, Gabriella Brazil, Kathryn Cieminski, Nicolas Calteux, Jennifer Parise, Catherine Coriell, Sarah Goetz, Christopher Moir, Amanda Moberly, Jocelyn Vallejo, Sasha Anderson, Hannah Wolf, Stacy Hopewell, Anna Galitsky, Lauren Rials and Kaitlyn Meassick.
Authorship and Contribution Policy
Dr. Marchand follows ICMJE authorship criteria. Authorship requires substantial contribution to conception or design, or to acquisition, analysis or interpretation of data; drafting or critical revision of the manuscript; final approval of the version to be published; and accountability for the work. Contributors who do not meet all four criteria are recognized in the acknowledgements rather than listed as authors. He does not offer or accept gift, guest or ghost authorship, and authorship positions are never sold.
All investigators declare no conflicts of interest. Dr. Marchand accepts no pharmaceutical or medical device industry funding for his research program.
Working With Dr. Marchand
Dr. Marchand regularly collaborates with outside clinicians, residents, fellows and students on systematic reviews and meta-analyses, and welcomes proposals for joint work. See Propose a Collaboration for what he looks for and how to submit an idea, or read about his review methodology and fellowship program.

